TScan TherapeuticsWaltham, United States
0997: Identification of Novel HLA Class II–Restricted Autoantigens in Scleroderma and Ulcerative Colitis Using TargetScan
Monday, October 27, 202510:30 AM - 12:30 PM Central Time
Disclosure information not submitted.